Hi Cody - Here are the relevant sections from t

Hi Cody -

Here are the relevant sections from the PR on the China deal...so GNBT, not just NGIO will get some upfront fees/licensing/royalty on Excellagen.

-Framework agreement outlines structure for project contracts:
Ii-Key Vaccine for COVID-19
Ii-Key Vaccine for Swine Flu
Ii-Key Platform for Cancer and Infectious Diseases
Impending contract to establish a Cancer Research Institute in China
Licensing Deal for Excellagen in China
100% funding for manufacturing, development and commercial registration of Ii-Key- SARS-CoV-2 vaccine against COVID-19 in and Ii-Key Swine Flu vaccine in China


Further, the framework includes a licensing agreement for Excellagen wound conforming gel matrix for the management of wounds in China.

We also expect to close a licensing deal for Excellagen® in which we will receive an upfront payment and royalties on sales of our novel and patented product for wound management.”


So, GNBT should probably get millions too as soon as the contract is signed for Excellagen.

Cody wrote -

is Olaregen part of the China deal? Or is is only NGIO?

Read More: https://investorshangout.com/post/newpost/622...z6cxo6vEEf